Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Jun. 30, 2019
Assets:    
Cash and cash equivalents $ 44,308 $ 30,054
Accounts receivable 351 285
Inventory 136 94
Other current assets 1,408 1,288
Total current assets 46,203 31,721
Property and equipment, net 23,605 15,178
Intangibles, net 544 388
Assets held for sale, net 21 300
Operating lease right-of-use asset, net 699
Restricted cash 100 100
Other assets 261 262
Total Assets 71,433 47,949
Current Liabilities:    
Accounts payable and accrued expenses 5,899 3,211
Contingent real estate liability 446
Operating lease liability-current 231
Deferred revenue 5
Total current liabilities 6,130 3,662
Long-term Liabilities:    
Convertible notes payable, net 21,628 18,215
Operating lease liability-non current 472
Loans payable 1,591
Other long-term liabilities 117 117
Total long-term liabilities 23,808 18,332
Total Liabilities 29,938 21,994
Stockholders’ Equity    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 37,990,380 and 30,140,955 shares issued and outstanding at June 30, 2020 and June 30, 2019, respectively 38 30
Additional paid in capital 145,072 93,399
Accumulated deficit (103,615) (67,474)
Total Stockholders’ Equity 41,495 25,955
Total Liabilities and Stockholders’ Equity $ 71,433 $ 47,949